Questions: Psychoactive Drugs: Mechanisms of Action and Behavioral Effects

Question 1

A patient who has taken benzodiazepines daily for six months abruptly stops. Based on their mechanism of action, which withdrawal symptoms should the clinician anticipate?

• A. Sedation and slowed breathing — the drug's effects persist in tissues after stopping
• B. Hyperexcitability, anxiety, and potentially seizures — the brain's compensatory changes are unmasked
• C. Intense cravings but no physical symptoms — benzodiazepines only cause psychological dependence
• D. Depression and fatigue — losing enhanced GABA activity causes the brain to become underactive

Answer: (B)

Benzodiazepines enhance GABA inhibition. With chronic use, the brain compensates by downregulating GABA receptors and reducing inhibitory tone — so the patient's nervous system is in a new, drug-dependent equilibrium. When the drug is removed, the compensatory changes are unmasked: the brain is now abnormally hyperexcitable. This can manifest as anxiety, tremors, and in severe cases, life-threatening seizures. Option A describes the drug's direct effects, not withdrawal. Option C confuses psychological with physical dependence. Option D inverts the logic: losing enhanced inhibition causes hyper-, not hypo-excitability.

Question 2

Both cocaine and amphetamines dramatically increase synaptic dopamine. What is the key mechanistic difference between them?

• A. Cocaine increases dopamine synthesis; amphetamines prevent dopamine breakdown
• B. Cocaine blocks the dopamine transporter (DAT), preventing reuptake; amphetamines reverse the transporter, actively pumping dopamine out of the presynaptic cell
• C. Cocaine acts on D2 receptors; amphetamines act on D1 receptors, producing different behavioral effects
• D. There is no meaningful mechanistic difference — both simply block the dopamine transporter equally

Answer: (B)

Cocaine is a reuptake blocker: it binds to the dopamine transporter and prevents it from clearing dopamine from the synapse, letting existing dopamine accumulate. Amphetamines are more aggressive: they are substrates for the transporter and, once inside the presynaptic terminal, reverse the transporter's direction so it pumps dopamine *out* rather than in. This produces a larger and faster dopamine surge. Option A describes biosynthesis/degradation mechanisms, which are not the primary targets. Option C incorrectly assigns receptor selectivity. Option D is factually wrong — the mechanism matters for addiction pharmacology and for designing treatments.

Question 3

Sensitization to a drug means that with repeated use, the subjective 'high' becomes more intense over time.

• T. True
• F. False

Answer: False

This conflates two different types of neural adaptation. The subjective high typically *tolerates* — the brain compensates for repeated drug exposure (e.g., by downregulating receptors), so more drug is needed to achieve the same pleasure. Sensitization refers specifically to an *enhanced* reactivity to drug-associated cues (sights, smells, locations) — not to the drug's direct rewarding effects. After repeated use, encountering a cue associated with the drug can trigger powerful cravings even years after abstinence, even when the person no longer experiences strong pleasure from the drug itself. This dissociation between wanting (sensitized) and liking (tolerating) is central to addiction theory.

Question 4

Opioids increase dopamine in the reward circuit by directly binding to and activating dopamine neurons.

• T. True
• F. False

Answer: False

Opioids use an indirect mechanism: they activate mu-opioid receptors on GABAergic *interneurons* in the reward circuit (particularly in the ventral tegmental area). These interneurons normally inhibit dopamine neurons. When opioids suppress the interneurons, the inhibition is lifted — dopamine neurons are *disinhibited* — and they fire more, releasing dopamine. This is called 'disinhibition.' The distinction matters clinically and scientifically: the reward effect is two synapses removed from the opioid receptor, and disrupting GABA circuits has consequences for many other brain functions beyond just dopamine release.

Question 5

Why is withdrawal from depressants like alcohol and benzodiazepines medically dangerous in a way that stimulant withdrawal typically is not?

Model answer: Depressants enhance GABA inhibition, so the brain adapts by reducing inhibitory tone — it becomes chronically underinhibited relative to the drug-free state. When the drug is removed, the compensatory hyperexcitability is fully expressed: the brain is now too excitable, which can escalate to uncontrolled neuronal firing (seizures) and autonomic instability that can be fatal. Stimulant withdrawal, by contrast, unmasks underactivity in reward circuits — causing fatigue, depression, and craving — but does not produce runaway excitation. The asymmetry is about what the compensatory changes are: hyperexcitability (depressant withdrawal) is more acutely life-threatening than hypoactivity (stimulant withdrawal).

This is why alcohol and benzodiazepine withdrawal in dependent patients is medically managed (often with tapering doses of benzodiazepines to gradually reduce the hyperexcitability), while stimulant withdrawal, though deeply uncomfortable, rarely requires emergency hospitalization. The underlying principle is that any drug that chronically tips the balance toward inhibition will cause compensatory excitatory changes that are dangerous when revealed by abrupt cessation.